CUSIP: 590328100
Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,252
-
Share change
-
-10,615
-
Total reported value
-
$368,000
-
Price per share
-
$31.55
-
Number of holders
-
4
-
Value change
-
-$17,275
-
Number of sells
-
2
Institutional Holders of MERRIMACK PHARMACEUTICALS IN - COM (MACK) as of Q4 2017
As of 31 Dec 2017,
MERRIMACK PHARMACEUTICALS IN - COM (MACK) was held by
4 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,252 shares.
The largest 4 holders included
DekaBank Deutsche Girozentrale, LeJeune Puetz Investment Counsel LLC, Virtue Capital Management, LLC, and Horrell Capital Management, Inc..
This page lists
4
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.